Penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into the normal equine ocular fluids.
Authors: Hermans Hanneke, van den Berg Els M H, Slenter Inge J M, Vendrig Dax J C, de Nijs-Tjon Lilian J L, Vernooij Johannes C M, Brommer Harold, Boevé Michael H, Gehring Ronette
Journal: Equine veterinary journal
Summary
# Topical Corticosteroid Penetration in Equine Eyes: A Pharmacokinetic Comparison Equine ophthalmologists routinely prescribe topical dexamethasone and prednisolone for inflammatory conditions like recurrent uveitis, yet direct comparative pharmacokinetic data in horses have been conspicuously absent, leaving practitioners largely reliant on empirical dosing protocols and extrapolations from other species. Hermans and colleagues measured drug concentration profiles in aqueous and vitreous humour following topical application of dexamethasone disodium phosphate and prednisolone acetate to normal equine eyes, establishing absorption patterns and intraocular bioavailability for each agent. The research provides quantitative evidence distinguishing between these two commonly used formulations—critical information for tailoring anti-inflammatory therapy to specific anterior versus posterior segment involvement. For practitioners managing equine uveitis or corneal inflammation, these findings offer pharmacological rationale for formulation selection and dosing frequency, potentially improving therapeutic outcomes whilst informing withdrawal period decisions in competition animals. This represents a valuable localisation of evidence-based prescribing guidance to equine patients, moving beyond species-extrapolated recommendations to species-specific data.
Read the full abstract on PubMed
Practical Takeaways
- •This pharmacokinetic comparison provides evidence-based guidance for choosing between dexamethasone and prednisolone for topical equine eye treatment, moving beyond empirical practice
- •Results can help optimize dosing regimens and treatment protocols for equine recurrent uveitis and other inflammatory eye conditions
- •Understanding drug penetration into ocular fluids allows veterinarians to make more informed decisions about which corticosteroid formulation provides better therapeutic coverage
Key Findings
- •Study compared penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into equine ocular fluids
- •Research addresses lack of comparative pharmacokinetic data in horses for corticosteroid ophthalmic treatments
- •Current treatment guidelines for equine ocular inflammation are based on empirical data rather than evidence-based pharmacokinetic studies